Diazoxide attenuates DOX-induced cardiotoxicity in cultured rat myocytes
Celal Guven,Eylem Taskin,Özgül Aydın,Salih Tunç Kaya,Yusuf Sevgiler,Celal GuvenEylem TaskinÖzgül AydınSalih Tunç KayaYusuf Sevgilera Department of Biophysics,Faculty of Medicine,Adıyaman University,Adıyaman,Turkeyb Department of Physiology,Faculty of Medicine,Adıyaman University,Adıyaman,Turkeyc Department of Biology,Institute of Natural and Applied Sciences,Adıyaman University,Adıyaman,Turkeyd Department of Biology,Faculty of Science and Letters,Düzce University,Düzce,Turkeye Department of Biology,Faculty of Science and Letters,Adıyaman University,Adıyaman,Turkey
DOI: https://doi.org/10.1080/10520295.2024.2324368
2024-03-06
Biotechnic & Histochemistry
Abstract:Doxorubicin (DOX)-induced cardiotoxicity is a well known clinical problem, and many investigations have been made of its possible amelioration. We have investigated whether diazoxide (DIA), an agonist at mitochondrial ATP-sensitive potassium channels (mitoK ATP ), could reverse DOX-induced apoptotic myocardial cell loss, in cultured rat cardiomyocytes. The role of certain proteins in this pathway was also studied. The rat cardiomyocyte cell line (H9c2) was treated with DOX, and also co-treated with DOX and DIA, for 24 h. Distribution of actin filaments, mitochondrial membrane potential, superoxide dismutase (SOD) activity, total oxidant and antioxidant status (TOS and TAS, respectively), and some protein expressions, were assessed. DOX significantly decreased SOD activity, increased ERK1/2 protein levels, and depolarised the mitochondrial membrane, while DIA co-treatment inhibited such changes. DIA co-treatment ameliorated DOX-induced cytoskeletal changes via F-actin distribution and mitoK ATP structure. Co-treatment also decreased ERK1/2 and cytochrome c protein levels. Cardiomyocyte loss due to oxidative stress-mediated apoptosis is a key event in DOX-induced cytotoxicity. DIA had protective effects on DOX-induced cardiotoxicity, via mitoK ATP integrity, especially with elevated SUR2A levels; but also by a cascade including SOD/AMPK/ERK1/2. Therefore, DIA may be considered a candidate agent for protecting cardiomyocytes against DOX chemotherapy.
biotechnology & applied microbiology,cell biology